Paradigm Medical Industries, Inc.
PDMI
$0.0001
$0.000.00%
OTC PK
| 03/31/2012 | 09/30/2011 | 06/30/2011 | 03/31/2011 | ||
|---|---|---|---|---|---|
| Revenue | -- | 55.19% | 34.55% | -4.09% | |
| Total Other Revenue | -- | -- | -- | -- | |
| Total Revenue | -- | 55.19% | 34.55% | -4.09% | |
| Cost of Revenue | -- | -3.46% | 9.75% | -20.00% | |
| Gross Profit | -- | 139.19% | 62.32% | 10.67% | |
| SG&A Expenses | -- | -15.09% | 1.67% | 12.97% | |
| Depreciation & Amortization | -- | -- | -- | -- | |
| Other Operating Expenses | -- | -- | -- | -- | |
| Total Operating Expenses | -- | -16.24% | 11.84% | 12.50% | |
| Operating Income | -- | 55.79% | 5.62% | -36.40% | |
| Income Before Tax | -- | 95.19% | 69.66% | 55.79% | |
| Income Tax Expenses | -- | -- | -- | -- | |
| Earnings from Continuing Operations | -- | 95.19% | 69.66% | 55.79% | |
| Earnings from Discontinued Operations | -- | -- | -- | -- | |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | |
| Minority Interest in Earnings | -- | -- | -- | -- | |
| Net Income | -- | 95.19% | 69.66% | 55.79% | |
| EBIT | -- | 55.79% | 5.62% | -36.40% | |
| EBITDA | -- | 57.20% | -18.82% | -115.84% | |
| EPS Basic | -- | 101.78% | 93.74% | 89.38% | |
| Normalized Basic EPS | -- | 85.90% | -40.54% | 27.19% | |
| EPS Diluted | -- | 101.78% | 93.74% | 89.38% | |
| Normalized Diluted EPS | -- | 85.90% | -40.54% | 27.19% | |
| Average Basic Shares Outstanding | -- | 2,342.21% | 524.85% | 753.45% | |
| Average Diluted Shares Outstanding | -- | 2,342.21% | 524.85% | 753.45% | |
| Dividend Per Share | -- | -- | -- | -- | |
| Payout Ratio | -- | -- | -- | -- | |